[Energy reserves and the extent of heart injury in ischemia and reperfusion during single and repeated administration of cardioplegic solutions].
Vavrínková
H
H
Tutterová
M
M
Vránová
Z
Z
D000227:Adenine Nucleotides / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002314:Cardioplegic Solutions / Q000008:administration & dosage*; D004734:Energy Metabolism; D006003:Glycogen / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D019344:Lactic Acid; D015428:Myocardial Reperfusion Injury / Q000378:metabolism* / Q000473:pathology; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D011919:Rats, Inbred Strains
D000227:Adenine Nucleotides; D002314:Cardioplegic Solutions; D007773:Lactates; D019344:Lactic Acid; D000255:Adenosine Triphosphate; D006003:Glycogen
Energetické rezervy a stupen poskození srdce bĕhem ischemie a reperfúze pri jednorázové a opakované aplikaci kardioplegického roztoku.